Dr. Reddy's Laboratories Ltd (RDY) Financials

RDY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 4.5 billion 1.3 billion
2023-09-30 4.2 billion 1.1 billion
2023-06-30 4.1 billion 675.4 million
2023-03-31 3.9 billion 1.1 billion

RDY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.7 million 1.2 million
2023-09-30 168.4 million 1.2 million
2023-06-30 -11.2 million 1.3 million
2023-03-31 193.9 million 255628

RDY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 165.6 million
2023-09-30 178.2 million
2023-06-30 171.1 million
2023-03-31 304.4 million

RDY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 869.2 million - 44.5 million
2023-09-30 816.3 million 72.8 million 43.1 million
2023-06-30 746.1 million - 27.5 million
2023-03-31 812.5 million 15.6 million 15.6 million

RDY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.0 million
2023-09-30 2.0 million
2023-06-30 2.0 million
2023-03-31 2.0 million

RDY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 60.6 million 66.8 million 243.0 million -
2023-09-30 47.4 million 65.6 million 347.5 million -
2023-06-30 148.5 million 60.8 million 215.9 million -
2023-03-31 45.6 million 65.3 million 155.3 million 189.1 million

RDY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 866.7 million 359.7 million
2023-09-30 828.6 million 342.4 million
2023-06-30 822.0 million 339.5 million
2023-03-31 766.5 million 137.7 million

RDY

Price: $74.55

52 week price:
53.12
77.72

Dividend Yield: 0.55%

5-year range yield:
0.55%
1.56%

Forward Dividend Yield: 1.29%

Payout Ratio: 25.60%

Payout Ratio Range:
9.97%
83.90%

Dividend Per Share: 0.97 USD

Earnings Per Share: 3.75 USD

P/E Ratio: 19.58

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 129000

Ebitda: 142.4 million

Market Capitalization: 12.2 billion

Average Dividend Frequency: 1

Years Paying Dividends: 22

DGR3: 5.95%

DGR5: 5.95%

DGR10: 3.84%

Links: